Skip to main content

Site notifications

AusPAR Nubeqa

Australian Public Assessment Report
Device/Product Name
Nubeqa
Active ingredients
Darolutamide
AusPAR Date
Published
Submission Number
PM-2022-00878-1-4
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site